Division of Endocrinology, Diabetes & Bone Disease and the Diabetes, Obesity, Metabolism Institute, Icahn School of Medicine at Sinai, 1 Gustave L. Levy Place, Atran 4(th) floor-36, Box 1055, New York, NY 10029-6574, USA.
Division of Endocrinology, Diabetes & Bone Disease and the Diabetes, Obesity, Metabolism Institute, Icahn School of Medicine at Sinai, 1 Gustave L. Levy Place, Atran 4(th) floor-36, Box 1055, New York, NY 10029-6574, USA.
Cell Metab. 2013 Jun 4;17(6):808-809. doi: 10.1016/j.cmet.2013.05.006.
A polymorphism in the fibroblast growth factor receptor 4 gene has been associated with cancer progression and treatment resistance and is now reported to increase insulin secretion, providing a possible genetic link between hyperinsulinemia and cancer (Ezzat et al., 2013).
成纤维细胞生长因子受体 4 基因的多态性与癌症的进展和治疗耐药性有关,现在有报道称其可增加胰岛素分泌,为高胰岛素血症和癌症之间的可能遗传联系提供了依据(Ezzat 等人,2013 年)。